Manufacturer Mandates and Claims Capture
Manufacturer Mandates and Claims Capture The environment created by some drug companies imposing conditions on the 340B drug pricing program statute has created financial challenges for entities across the country. As the Department of Justice attorney’s representing the Department of Health and Human Services file appeal, entities must continue to
January 25, 2022